MALI COVID-19 EMERGENCY RESPONSE PROJECT

Abstract*

An outbreak of the coronavirus disease (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) has been spreading rapidly across the world since December 2019, following the diagnosis of the initial cases in Wuhan, Hubei Province, China. The objective of this project is to strengthen the capacity of the government of Mali to prevent, prepare for and respond to COVID-19 pandemic in Mali. It has 4 Components: Component 1 (US 12.7 million): Emergency... Show More

Development Objective

The objective of the Project is to strengthen the capacity of the Recipient to prevent, prepare for and respond to COVID-19 pandemic

Key Details

Project Details

Project ID
P173816
Status
Closed
Team Leader
Alain-Desire Karibwami , Laurence Lannes, Jean Taptue Fotso
Borrower 2
THE REPUBLIC OF MALI

Country
Mali
Disclosure Date
April 2, 2020
Approval Date
(as of board presentation)
April 10, 2020
Effective Date
May 13, 2020

Total Project Cost 1
US$ 25.80 million
Implementing Agency
Ministry of Health and Social Development
Region
Western and Central Africa
Fiscal Year 3
2020

Commitment Amount
US$ 25.80 million
Environmental Category
N/A
Environmental and Social Risk
Substantial
Closing Date
December 31, 2023

Consultant Services required
TBD
Last Stage Reached
BANK APPROVED
Last Update Date
December 28, 2023

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control100%
- FY17 - Pandemic Response100%
FY17 - Health Systems and Policies54%
- FY17 - Health Finance54%
- FY17 - Health Service Delivery54%
- FY17 - Health System Strengthening19%

FY17 - Social Development and Protection

FY17 - Social Protection19%
- FY17 - Social Safety Nets19%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
IDA Credit	12.90
IDA Grant	12.90

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	N/A
IDA Commitment	25.80
IBRD + IDA Commitment	25.80

Lending Instrument
Grant Amount	N/A
Total Project Cost**	25.80

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

No data available.

Detailed Financial Activity as of March 31, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Feb 9, 2021	IDA-D6150	Loan Disb	367,169.00
Mar 3, 2021	IDA-66180	Loan Disb	446,332.25
Feb 26, 2021	IDA-66180	Loan Disb	3,401,995.20
Nov 19, 2020	IDA-D6150	Loan Disb	297,258.80
Jun 8, 2020	IDA-D6150	Loan Disb	6,506,738.00
Sep 25, 2020	IDA-D6150	Loan Disb	446,979.30
Aug 17, 2020	IDA-D6150	Loan Disb	1,040,475.75
Mar 2, 2021	IDA-66180	Loan Disb	534,277.80
Sep 23, 2021	IDA-69920	Loan Commitment	26,250,000.00
Sep 23, 2021	IDA-D9100	Loan Commitment	26,250,000.00
Apr 10, 2020	IDA-66180	Loan Commitment	12,900,000.00
Apr 10, 2020	IDA-D6150	Loan Commitment	12,900,000.00
Jan 2, 2024	IDA-66180	Loan Disb	-1,672,213.20
Nov 21, 2023	IDA-69920	Loan Disb	47,636.27
Jun 10, 2024	IDA-69920	Int Charges	77,489.14
Jun 10, 2024	IDA-69920	Int Charges	77,489.14
Jun 10, 2024	IDA-66180	Int Charges	88.91
Jun 10, 2024	IDA-66180	Int Charges	88.91
Jun 10, 2024	IDA-66180	Int Charges	39,217.06
Jun 10, 2024	IDA-66180	Int Charges	39,217.06
Jun 10, 2024	IDA-69920	Int Charges	302.54
Aug 14, 2024	IDA-D9100	Loan Disb	-502,051.50
Jun 10, 2024	IDA-69920	Int Charges	302.54
Jun 11, 2024	IDA-D9100	Loan Disb	-11,099.00
May 22, 2023	IDA-D9100	Loan Disb	459,969.00
May 24, 2023	IDA-69920	Loan Disb	1,712,934.00
Nov 10, 2023	IDA-69920	Loan Disb	488,517.12
Dec 21, 2023	IDA-66180	Loan Cancel	112,509.39
Dec 21, 2023	IDA-69920	Loan Cancel	2,854,800.00
Dec 27, 2023	IDA-69920	Int Charges	8,512.43
Dec 27, 2023	IDA-69920	Int Charges	8,512.43
Dec 27, 2023	IDA-69920	Int Charges	72,165.80
Dec 27, 2023	IDA-69920	Int Charges	72,165.80
Dec 27, 2023	IDA-66180	Int Charges	45,054.16
Dec 27, 2023	IDA-66180	Int Charges	642.62
Dec 27, 2023	IDA-66180	Int Charges	642.62
Dec 27, 2023	IDA-66180	Int Charges	45,054.16
Sep 18, 2023	IDA-69920	Loan Disb	120,485.37
Sep 5, 2023	IDA-69920	Loan Disb	1,228,023.50
Jun 9, 2023	IDA-69920	Loan Disb	546,213.75
Jul 25, 2023	IDA-69920	Loan Disb	148,438.48
Aug 31, 2023	IDA-69920	Loan Disb	146,583.14
Jun 21, 2023	IDA-69920	Loan Disb	1,389,054.90
Aug 16, 2023	IDA-D9100	Loan Disb	244,179.00
Jun 5, 2023	IDA-66180	Int Charges	40,032.20
Jun 5, 2023	IDA-66180	Int Charges	40,032.20
Jun 5, 2023	IDA-66180	Int Charges	267.28
Jun 5, 2023	IDA-66180	Int Charges	267.28
Sep 19, 2022	IDA-D9100	Loan Disb	1,197,156.00
Apr 14, 2023	IDA-69920	Loan Disb	3,293,944.80
Mar 27, 2023	IDA-66180	Loan Disb	544,389.80
Apr 11, 2023	IDA-69920	Loan Disb	8,903,272.00
May 15, 2023	IDA-69920	Loan Disb	2,985,811.20
May 17, 2023	IDA-D9100	Loan Disb	14,168,491.00
May 11, 2023	IDA-D9100	Loan Disb	279,438.00
Mar 1, 2023	IDA-66180	Loan Disb	218,782.06
Aug 30, 2022	IDA-D9100	Loan Disb	1,904,268.60
Feb 4, 2022	IDA-D6150	Loan Disb	235,402.70
Jul 28, 2022	IDA-66180	Loan Disb	145,901.20
Jul 28, 2022	IDA-66180	Loan Disb	123,326.22
Dec 27, 2022	IDA-66180	Loan Disb	810,705.60
Dec 21, 2022	IDA-66180	Loan Disb	121,400.33
Nov 17, 2022	IDA-66180	Int Charges	27,026.40
Nov 18, 2022	IDA-66180	Loan Disb	47,634.72
Nov 17, 2022	IDA-66180	Loan Disb	112,658.93
Nov 28, 2022	IDA-66180	Loan Disb	779,808.56
Nov 17, 2022	IDA-66180	Int Charges	54.37
Nov 17, 2022	IDA-66180	Int Charges	54.37
Nov 17, 2022	IDA-66180	Int Charges	27,026.40
Sep 16, 2022	IDA-66180	Loan Disb	56,155.80
Sep 20, 2022	IDA-D9100	Loan Disb	1,902,558.60
Nov 10, 2022	IDA-66180	Loan Disb	1,225,543.90
Oct 21, 2022	IDA-D9100	Loan Disb	3,523,566.00
Jul 12, 2022	IDA-66180	Int Charges	25,504.24
Jul 12, 2022	IDA-66180	Int Charges	25,504.24
Aug 24, 2022	IDA-66180	Loan Disb	44,480.18
Nov 2, 2021	IDA-66180	Loan Disb	3,046,522.80
Nov 8, 2021	IDA-66180	Loan Disb	216,230.44
Jul 12, 2022	IDA-66180	Int Charges	769.72
Jul 12, 2022	IDA-66180	Int Charges	769.72
Feb 26, 2021	IDA-66180	Loan Disb	442,783.50
May 25, 2021	IDA-66180	Int Charges	7,908.53
May 25, 2021	IDA-66180	Int Charges	7,908.53
Nov 17, 2021	IDA-66180	Int Charges	16,908.50
Nov 17, 2021	IDA-66180	Int Charges	16,908.50
Nov 20, 2020	IDA-D6150	Loan Disb	679,274.00
Nov 20, 2020	IDA-D6150	Loan Disb	1,177,408.20
Nov 20, 2020	IDA-D6150	Loan Disb	506,285.53
Nov 20, 2020	IDA-D6150	Loan Disb	1,426,475.40
Feb 9, 2021	IDA-D6150	Loan Disb	410,557.38

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Overall Implementation Progress (IP)	Satisfactory	2023-12-22
Monitoring and Evaluation	Satisfactory	2023-12-22
Project Management	Satisfactory	2023-12-22
Progress towards achievement of PDO	Highly Satisfactory	2023-12-22
Procurement	Satisfactory	2023-12-22
Financial Management	Moderately Satisfactory	2023-12-22

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Number of suspected cases of COVID-19 cases reported and investigated based on national guidelines Value 171.00 779113.00 100000.00
Date April 7, 2020 March 1, 2024 December 29, 2023
Comment
Number of beds in Intensive Care Unit (ICU) available to appropriately handle severe cases Value 1.00 374.00 327.00
Date April 7, 2020 March 1, 2024 December 29, 2023
Comment
Percentage of laboratory confirmed cases of COVID-19 treated per approved protocol Value 0.00 100.00 95.00
Date April 7, 2020 March 1, 2024 December 29, 2023
Comment
Percentage of population vaccinated, which is included in the priority population targets defined in national plan Value 0.00 57.00 35.70
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment
Percentage of female population vaccinated, which is included in the priority population targets defined in national plan Value 0.00 56.00 35.70
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment
Percentage of male population vaccinated, which is included in the priority population targets defined in national plan Value 0.00 58.00 35.70
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Number of national weekly report on epidemic surveillance issued Value 11.00 156.00 52.00
Date April 7, 2020 March 1, 2024 December 29, 2023
Comment

Percentage of health centers/district hospitals with 100% of surveillance report sent to the health district or to the region per Ministry of Health Guidelines	Value	53.00	100.00	95.00
	Date	April 7, 2020	March 1, 2024	December 29, 2023
	Comment

Number of treatment, isolation & quarantine centers which received weekly supportive supervision and monthly review meetings Value 23.00 23.00 20.00
Date April 7, 2020 March 1, 2024 December 29, 2023
Comment
Number of health workers trained on case definition, management, infection prevention and control for COVID-19 Value 0.00 8264.00 8264.00
Date April 7, 2020 March 1, 2024 December 29, 2023
Comment
Number of treatment, isolation & quarantine centers preparing daily report Value 7.00 23.00 20.00
Date April 7, 2020 March 1, 2024 December 29, 2023
Comment

Number of isolation centers, screening sites and quarantine centers established and equipped with medical supplies, protective equipment and laundry machines	Value	3.00	23.00	20.00
	Date	April 7, 2020	March 1, 2024	December 29, 2023
	Comment

Number of treatment, isolation & quarantine centers that are assessed monthly using a checklist Value 0.00 23.00 20.00
Date April 7, 2020 March 1, 2024 December 29, 2023
Comment
Number of Vaccinators trained on GBV/SEA/SH Value 0.00 191.00 200.00
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment
Proportion of complaints managed according to project GRM protocol Value 0.00 98.00 50.00
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment
Proportion of vaccination team members who are Women Value 0.00 34.00 30.00
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment

Number of designated laboratories with COVID-19 functioning diagnostic equipment, test kits, and reagents per Ministry of Health guidelines	Value	4.00	28.00	10.00
	Date	April 7, 2020	March 1, 2024	December 29, 2023
	Comment

Percentage of target population who received their first dose of the COVID-19 vaccine Value 0.00 64.00 35.70
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment
Percentage of female target population who received their first dose of the COVID-19 vaccine Value 0.00 63.00 35.70
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment
Percentage of male target population who received their first dose of the COVID-19 vaccine Value 0.00 65.00 35.70
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment
Percentage of the target population fully vaccinated with COVID-19 vaccine Value 0.00 57.00 35.70
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment
Percentage of female target population fully vaccinated with COVID-19 vaccine Value 0.00 56.00 35.70
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment
Percentage of male target population fully vaccinated with COVID-19 vaccine Value 0.00 58.00 35.70
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment
Proportion of health regions with an AEFI monitoring committee Value 0.00 86.60 80.00
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment
Proportion of health districts with a budgeted micro-plan for COVID-19 vaccination campaign Value 0.00 100.00 80.00
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment
Number of local radio stations communicating awareness campaigns about COVID-19 and the COVID-19 campaign Value 0.00 310.00 8.00
Date March 1, 2021 March 1, 2024 December 29, 2023
Comment

Number of suspected cases of COVID-19 cases reported and investigated based on national guidelines	Value	171.00	779113.00	100000.00
	Date	April 7, 2020	March 1, 2024	December 29, 2023
	Comment

Number of beds in Intensive Care Unit (ICU) available to appropriately handle severe cases	Value	1.00	374.00	327.00
	Date	April 7, 2020	March 1, 2024	December 29, 2023
	Comment

Percentage of laboratory confirmed cases of COVID-19 treated per approved protocol	Value	0.00	100.00	95.00
	Date	April 7, 2020	March 1, 2024	December 29, 2023
	Comment

Number of national weekly report on epidemic surveillance issued	Value	11.00	156.00	52.00
	Date	April 7, 2020	March 1, 2024	December 29, 2023
	Comment

Number of treatment, isolation & quarantine centers preparing daily report	Value	7.00	23.00	20.00
	Date	April 7, 2020	March 1, 2024	December 29, 2023
	Comment

MALI COVID-19 EMERGENCY RESPONSE PROJECT

Abstract*

Development Objective

Key Details

Project Details

Sectors

Themes

Stay Connected, sign up for our:

Project Map

Finances

Financing Plan (US$ Millions)

Total Project Financing (US$ Millions)

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Detailed Financial Activity as of March 31, 2025

Ratings

IMPLEMENTATION RATINGS

COMPLETION RATINGS

INDEPENDENT EVALUATION RATINGS

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INTERMEDIATE RESULTS INDICATORS